Zim Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹105.27 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.12 per cent from ₹108.66 crore. This corresponds to a year-on-year *(YoY) decline of 3.18 per cent.
Operating Profit
Operating Profit stands at ₹7.19 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 43.87 per cent from ₹12.81 crore. This corresponds to a year-on-year *(YoY) decline of 50.72 per cent.
PBDT
PBDT stands at ₹10.04 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 9.39 per cent from ₹11.08 crore. This corresponds to a year-on-year *(YoY) decline of 25.02 per cent.
Profit Before Tax
Profit Before Tax stands at ₹4.94 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.35 per cent from ₹6.05 crore. This corresponds to a year-on-year *(YoY) decline of 39.01 per cent.
Net Profit
Net Profit stands at ₹3.74 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 15.00 per cent from ₹4.40 crore. This represents a 23.36 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Zim Laboratories Ltd Earnings
- YOY
- QOQ
Zim Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Zim Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Zim Laboratories Ltd Financial Reports
Zim Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Zim Laboratories | -0.04% | -4.00% | -4.99% | 39.00% | 72.66% | 8.65% |
| Kopran | -2.98% | -2.31% | 6.82% | 24.35% | 55.57% | 12.18% |
| Shree Ganesh Rem | -2.58% | -0.23% | -4.58% | 23.50% | 60.59% | 11.97% |
| Anuh Pharma | -0.31% | -1.49% | -1.04% | -4.49% | 10.73% | -18.76% |
| Amanta Healthcar | -0.61% | -1.30% | -0.52% | 21.77% | 63.90% | 15.89% |
| Kilitch Drugs | 1.84% | 0.06% | -4.91% | 14.92% | 13.41% | -19.45% |
| Bafna Pharma. | 1.07% | 6.99% | 17.62% | 73.76% | 106.75% | 173.80% |
Company Info
Company Information
Chairman & Non Executive Dir. : Anwar Daud
ED / Whole Time Director / Promoter : Zulfiquar Kamal
E D & Wholetime Director : Niraj Dhadiwal
E D & Wholetime Director : Prakash Sapkal
Independent Director : Kavita Loya
Independent Director : Padmakar S. Joshi
Independent Director : Kamlesh Shende
Independent Director : Ashok Bhatia
Company Sec. & Compli. Officer : Piyush Nikhade